Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00322_DB00440_nanopub.RAd4PjHISCC_xS6wDSxqaCJ1x8IEvI7y0hEz2Y3GTgP28#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00322_DB00440 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00322_DB00440 label "DDI between Floxuridine and Trimethoprim - The strong CYP2C9 inhibitor, Floxuridine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Floxuridine is initiated, discontinued or dose changed. [drugbank_resource:DB00322_DB00440]" assertion.
- drugbank_resource:DB00322_DB00440 identifier "drugbank_resource:DB00322_DB00440" assertion.
- drugbank_resource:DB00322_DB00440 title "DDI between Floxuridine and Trimethoprim - The strong CYP2C9 inhibitor, Floxuridine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Floxuridine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00322 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00322_DB00440 assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00322_DB00440 assertion.